Global Drugs for Schistosomiasis Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Drugs for Schistosomiasis Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Praziquantel
- 1.3.3 Oxamniquine
- 1.3.4 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Drugs for Schistosomiasis Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 S. haematobium
- 1.4.3 S. mansoni
- 1.4.4 S. japonicum
- 1.4.5 S. mekongi
- 1.4.6 S. intercalatum
- 1.5 Global Drugs for Schistosomiasis Market Size & Forecast
- 1.5.1 Global Drugs for Schistosomiasis Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Drugs for Schistosomiasis Sales Quantity (2020-2031)
- 1.5.3 Global Drugs for Schistosomiasis Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Shin Poong
- 2.1.1 Shin Poong Details
- 2.1.2 Shin Poong Major Business
- 2.1.3 Shin Poong Drugs for Schistosomiasis Product and Services
- 2.1.4 Shin Poong Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Shin Poong Recent Developments/Updates
- 2.2 Merck
- 2.2.1 Merck Details
- 2.2.2 Merck Major Business
- 2.2.3 Merck Drugs for Schistosomiasis Product and Services
- 2.2.4 Merck Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Merck Recent Developments/Updates
- 2.3 Bayer
- 2.3.1 Bayer Details
- 2.3.2 Bayer Major Business
- 2.3.3 Bayer Drugs for Schistosomiasis Product and Services
- 2.3.4 Bayer Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Bayer Recent Developments/Updates
- 2.4 EIPICO
- 2.4.1 EIPICO Details
- 2.4.2 EIPICO Major Business
- 2.4.3 EIPICO Drugs for Schistosomiasis Product and Services
- 2.4.4 EIPICO Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 EIPICO Recent Developments/Updates
- 2.5 Chandra Bhagat Pharma
- 2.5.1 Chandra Bhagat Pharma Details
- 2.5.2 Chandra Bhagat Pharma Major Business
- 2.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Product and Services
- 2.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Chandra Bhagat Pharma Recent Developments/Updates
- 2.6 Taj Pharmaceuticals
- 2.6.1 Taj Pharmaceuticals Details
- 2.6.2 Taj Pharmaceuticals Major Business
- 2.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Product and Services
- 2.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Taj Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Drugs for Schistosomiasis by Manufacturer
- 3.1 Global Drugs for Schistosomiasis Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Drugs for Schistosomiasis Revenue by Manufacturer (2020-2025)
- 3.3 Global Drugs for Schistosomiasis Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Drugs for Schistosomiasis by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2024
- 3.4.3 Top 6 Drugs for Schistosomiasis Manufacturer Market Share in 2024
- 3.5 Drugs for Schistosomiasis Market: Overall Company Footprint Analysis
- 3.5.1 Drugs for Schistosomiasis Market: Region Footprint
- 3.5.2 Drugs for Schistosomiasis Market: Company Product Type Footprint
- 3.5.3 Drugs for Schistosomiasis Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Drugs for Schistosomiasis Market Size by Region
- 4.1.1 Global Drugs for Schistosomiasis Sales Quantity by Region (2020-2031)
- 4.1.2 Global Drugs for Schistosomiasis Consumption Value by Region (2020-2031)
- 4.1.3 Global Drugs for Schistosomiasis Average Price by Region (2020-2031)
- 4.2 North America Drugs for Schistosomiasis Consumption Value (2020-2031)
- 4.3 Europe Drugs for Schistosomiasis Consumption Value (2020-2031)
- 4.4 Asia-Pacific Drugs for Schistosomiasis Consumption Value (2020-2031)
- 4.5 South America Drugs for Schistosomiasis Consumption Value (2020-2031)
- 4.6 Middle East & Africa Drugs for Schistosomiasis Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Drugs for Schistosomiasis Sales Quantity by Type (2020-2031)
- 5.2 Global Drugs for Schistosomiasis Consumption Value by Type (2020-2031)
- 5.3 Global Drugs for Schistosomiasis Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Drugs for Schistosomiasis Sales Quantity by Application (2020-2031)
- 6.2 Global Drugs for Schistosomiasis Consumption Value by Application (2020-2031)
- 6.3 Global Drugs for Schistosomiasis Average Price by Application (2020-2031)
7 North America
- 7.1 North America Drugs for Schistosomiasis Sales Quantity by Type (2020-2031)
- 7.2 North America Drugs for Schistosomiasis Sales Quantity by Application (2020-2031)
- 7.3 North America Drugs for Schistosomiasis Market Size by Country
- 7.3.1 North America Drugs for Schistosomiasis Sales Quantity by Country (2020-2031)
- 7.3.2 North America Drugs for Schistosomiasis Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Drugs for Schistosomiasis Sales Quantity by Type (2020-2031)
- 8.2 Europe Drugs for Schistosomiasis Sales Quantity by Application (2020-2031)
- 8.3 Europe Drugs for Schistosomiasis Market Size by Country
- 8.3.1 Europe Drugs for Schistosomiasis Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Drugs for Schistosomiasis Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Drugs for Schistosomiasis Market Size by Region
- 9.3.1 Asia-Pacific Drugs for Schistosomiasis Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Drugs for Schistosomiasis Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Drugs for Schistosomiasis Sales Quantity by Type (2020-2031)
- 10.2 South America Drugs for Schistosomiasis Sales Quantity by Application (2020-2031)
- 10.3 South America Drugs for Schistosomiasis Market Size by Country
- 10.3.1 South America Drugs for Schistosomiasis Sales Quantity by Country (2020-2031)
- 10.3.2 South America Drugs for Schistosomiasis Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Drugs for Schistosomiasis Market Size by Country
- 11.3.1 Middle East & Africa Drugs for Schistosomiasis Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Drugs for Schistosomiasis Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Drugs for Schistosomiasis Market Drivers
- 12.2 Drugs for Schistosomiasis Market Restraints
- 12.3 Drugs for Schistosomiasis Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Drugs for Schistosomiasis and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Drugs for Schistosomiasis
- 13.3 Drugs for Schistosomiasis Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Drugs for Schistosomiasis Typical Distributors
- 14.3 Drugs for Schistosomiasis Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Drugs for Schistosomiasis market size was valued at US$ 90.9 million in 2024 and is forecast to a readjusted size of USD 117 million by 2031 with a CAGR of 3.7% during review period.
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).
This report is a detailed and comprehensive analysis for global Drugs for Schistosomiasis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drugs for Schistosomiasis market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Units), 2020-2031
Global Drugs for Schistosomiasis market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Units), 2020-2031
Global Drugs for Schistosomiasis market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Units), 2020-2031
Global Drugs for Schistosomiasis market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/K Units), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drugs for Schistosomiasis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drugs for Schistosomiasis market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma, Taj Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Drugs for Schistosomiasis market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Praziquantel
Oxamniquine
Other
Market segment by Application
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
Major players covered
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for Schistosomiasis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Drugs for Schistosomiasis, with price, sales quantity, revenue, and global market share of Drugs for Schistosomiasis from 2020 to 2025.
Chapter 3, the Drugs for Schistosomiasis competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for Schistosomiasis breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Drugs for Schistosomiasis market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Drugs for Schistosomiasis.
Chapter 14 and 15, to describe Drugs for Schistosomiasis sales channel, distributors, customers, research findings and conclusion.